Abbreviation | Formula | Mass | Main Class | Sub Class |
---|---|---|---|---|
Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C52H97NO18 | 1023.670570 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C54H101NO18 | 1051.701871 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C56H105NO18 | 1079.733171 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 | C58H109NO18 | 1107.764471 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 | C60H111NO18 | 1133.780121 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 | C60H113NO18 | 1135.795771 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 | C62H115NO18 | 1161.811421 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 | C62H117NO18 | 1163.827071 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C58H107NO23 | 1185.723396 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C58H107NO23 | 1185.723396 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C60H111NO23 | 1213.754696 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C60H111NO23 | 1213.754696 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C60H110N2O23 | 1226.749944 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C60H110N2O23 | 1226.749944 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C62H115NO23 | 1241.785996 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C62H115NO23 | 1241.785996 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C62H114N2O23 | 1254.781245 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C62H114N2O23 | 1254.781245 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 | C64H119NO23 | 1269.817296 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 | C64H119NO23 | 1269.817296 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C64H118N2O23 | 1282.812545 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C64H118N2O23 | 1282.812545 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 | C66H121NO23 | 1295.832946 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 | C66H121NO23 | 1295.832946 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 | C66H123NO23 | 1297.848596 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 | C66H123NO23 | 1297.848596 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 | C66H122N2O23 | 1310.843845 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 | C66H122N2O23 | 1310.843845 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 | C68H125NO23 | 1323.864246 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 | C68H125NO23 | 1323.864246 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 | C68H127NO23 | 1325.879896 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 | C68H127NO23 | 1325.879896 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C64H117NO27 | 1331.781306 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 | C68H124N2O23 | 1336.859495 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 | C68H124N2O23 | 1336.859495 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 | C68H126N2O23 | 1338.875145 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 | C68H126N2O23 | 1338.875145 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C64H117NO28 | 1347.776221 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C66H121NO27 | 1359.812606 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 | C70H128N2O23 | 1364.890795 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 | C70H128N2O23 | 1364.890795 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 | C70H130N2O23 | 1366.906445 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 | C70H130N2O23 | 1366.906445 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 | C66H121NO28 | 1375.807521 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C68H125NO27 | 1387.843906 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 | C68H125NO28 | 1403.838821 | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] |